Next-Generation Infection Screening.
Technology Overview
The CytoTracker Leukometer represents a breakthrough in point-of-care diagnostics, combining advanced microfluidics with powerful AI to deliver a rapid and detailed white blood cell count and two-part differential from a single drop of blood. This handheld innovation brings critical diagnostic capabilities out of the core lab and directly to the patient's side, empowering clinicians to make faster, more informed decisions.
Leukometer-Enabled Future Workflow.
01
Triage
A drop of blood is collected by the nurse, either by fingerstick or from a venous draw
02
Point-of-Care Test
The blood sample is loaded into a disposable cartridge and placed in CytoTracker at the triage desk
04
Immediate Decision
Clinicians can act right away by fast-tracking high-risk patients for urgent care, or safely discharging those who do not require bed assignment
03
Rapid Analysis
Using microfluidics and AI, CytoTracker delivers WBC counts, differentials, and immune profiling in under 6 minutes
Time Saved
Results under 6 minutes
Cost Saved
Reduces lab workload, ER congestion, and prevents costly complications
Key Capabilities
Rapid WBC differentiation
Instant insights into key white blood cell populations for infection screening.
Bacterial vs. viral Guidance
Helps clinicians decide on the right treatment pathway, supporting antibiotic stewardship.
Early sepsis detection
Flags high-risk patients at triage for faster intervention and improved outcomes.
LOIs & Support
““Since the pandemic, hospital ERs have been backed up. If we can test infected patients for their white counts in triage, we can determine who needs elevated priority in care.”
— Greg Martin, MD
Infectious Disease
“Even 20 minutes earlier clinical decision can make the difference between life and death for a sepsis patient. If I see a high WBC count, I want the patients on abx immediately.”
— Annette Aesper, MD
Emergency Medicine
FAQs
-
CytoTracker is designed for rapid infection disease screening. By analyzing WBC, lymphocytes, and neutrophils, it helps clinicians distinguish between bacterial and viral immune responses and identify patients at risk of deterioration, including sepsis.
-
By enabling clinicians to spot bacterial versus viral immune patterns within minutes, CytoTracker helps reduce unnecessary antibiotic prescriptions and ensures antibiotics are started quickly when they are truly needed. This supports better patient outcomes and global antimicrobial resistance (AMR) efforts.
-
CytoTracker provides absolute counts of total white blood cells (WBC), lymphocytes, and neutrophils.
-
Early validation studies show CytoTracker delivers clinical-grade performance, with results closely aligned to central laboratory CBCs and gold-standard hematology instruments. Larger pivotal studies are planned are ongoing as part of the FDA 510(k) submission.
-
No. CytoTracker is fully electronic with no moving parts. It requires no calibration, no service contracts, and only quality controls — making it truly maintenance-free.
-
CytoTracker is preparing for FDA 510(k) submission and CE-IVDR (Europe), and other national approvals to follow.
-
Yes. Rizlab has received Letters of Support and Letters of Intent from leading hospitals, clinicians, and distribution partners worldwide. These confirm strong clinical interest and the potential health-economic impact of CytoTracker.
